An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“orthogonally confirmed dose-dependent KAT2A degradation by western blot, and demonstrated that this degradation can be rescued by pre-treatment with a UBA3/NAE1 inhibitor, MLN4924 (37), a proteasome inhibitor, bortezomib (38), and a competing CRBN ligand, pomalidomide (7) (Fig. 1D).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [37]
In the citing paper
“we cotreated cells with a proteasome inhibitor (bortezomib) or a NEDD8-activating enzyme E1 inhibitor (MLN-4924 32 ) and found that both inhibitors prevented degradation of BTK (Figure 2D).”
From Bruton tyrosine kinase degradation as a therapeutic strategy for cancer (2019) · cites this paper as [32]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-508 · Cited by 628
Cited by
Items 401–500 of 1,005
Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection
Ferretti, L. P., Himmels, S.-F., Trenner, A., Walker, C., von Aesch, C., Eggenschwiler, A., Murina, O., Enchev, R. I., Peter, M., Freire, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms12628 · Cited by 70
Ding, S., Mooney, N. A., Li, B., Kelly, M. R., Feng, N., Loktev, A. V., Sen, A., Patton, J. T., Jackson, P. K., & Greenberg, H. B. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005929 · Cited by 76
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.
Zhong, J., Ogura, K., Wang, Z. P., & Inuzuka, H. (2013) · PubMed · Cited by 78
Monomeric Targeted Protein Degraders
Hanan, E. J., Liang, J., Wang, X., Blake, R. A., Blaquiere, N., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00093 · Cited by 69
Targeting neddylation E2s: a novel therapeutic strategy in cancer
Zheng, Y., Guo, Y.-J., Wang, B., Wang, C., Mamun, M., Gao, Y., & Liu, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01070-w · Cited by 71
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, J., Abeliovich, H., Acevedo‐Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Parasites & Vectors · doi:10.5167/uzh-131237 · Cited by 161
Rational Screening for Cooperativity in Small-Molecule Inducers of Protein–Protein Associations
Liu, S., Tong, B., Mason, J. W., Ostrem, J. M. L., Tutter, A. V., Hua, B. K., Tang, S. A., Bonazzi, S., Briner, K., Berst, F., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08307 · Cited by 73
Curtis, V. F., Ehrentraut, S., Campbell, E. L., Glover, L. E., Bayless, A., Kelly, C. J., Kominsky, D. J., & Colgan, S. P. (2014) · The FASEB Journal · doi:10.1096/fj.14-259663 · Cited by 70
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein–Protein Interaction
Zhou, H., Zhou, W., Zhou, B. N., Liu, L., Chern, T., Chinnaswamy, K., Lü, J., Bernard, D., Yang, C., Li, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01455 · Cited by 69
Huber, M. E., Toy, L., Schmidt, M. F., Vogt, H., Budzinski, J., Wiefhoff, M. F. J., Merten, N., Kostenis, E., Weikert, D., & Schiedel, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202116782 · Cited by 68
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive Chemistry
Sarott, R. C., You, I., Li, Y.-D., Toenjes, S. T., Donovan, K. A., Seo, P., Ordonez, M., Byun, W. S., Hassan, M. M., Wachter, F., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06622 · Cited by 71
Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application
Zhao, Y., & Sun, Y. (2012) · Neoplasia · doi:10.1593/neo.12532 · Cited by 74
Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents
Kee, Y., Huang, M., Chang, S. C., Moreau, L. A., Park, E., Smith, P. G., & D’Andrea, A. D. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0497 · Cited by 68
Self-citationRhodium complexes as therapeutic agents
Ma, D., Wang, M., Mao, Z., Yang, C., Ng, C. E., & Leung, C. (2015) · Dalton Transactions · doi:10.1039/c5dt04338g · Cited by 68
Zhou, X., Tan, M., Nyati, M. K., Zhao, Y., Wang, G., & Sun, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522367113 · Cited by 74
Lu, R., Hu, X., Zhou, J., Sun, J., Zhu, A. Z., Xu, X., Zheng, H., Gao, X., Wang, X., Jin, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12044 · Cited by 74
Expanding the host cell ubiquitylation machinery targeting cytosolic Salmonella
Polajnar, M., Dietz, M. S., Heilemann, M., & Behrends, C. (2017) · EMBO Reports · doi:10.15252/embr.201643851 · Cited by 68
Targeting Chromatin Remodeling for Cancer Therapy
Kaur, J., Daoud, A., & Eblen, S. T. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190215112915 · Cited by 73
Yoshimura, C., Muraoka, H., Ochiiwa, H., Tsuji, S., Hashimoto, A., Kazuno, H., Nakagawa, F., Komiya, Y., Suzuki, S. O., Takenaka, T., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0644 · Cited by 69
Simpson, L. M., Macartney, T., Nardin, A., Fulcher, L. J., Röth, S., Testa, A., Maniaci, C., Ciulli, A., Ganley, I. G., & Sapkota, G. P. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.06.013 · Cited by 74
A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation
Morgan, M. A., Rickels, R. A., Collings, C. K., He, X. L., Cao, K., Herz, H., Cozzolino, K., Abshiru, N. A., Marshall, S. A., Rendleman, E. J., et al. (2017) · Genes & Development · doi:10.1101/gad.305201.117 · Cited by 72
Advancing Cell Biology Through Proteomics in Space and Time (PROSPECTS)
Lamond, A. I., Uhlén, M., Horning, S. R., Makarov, A., Robinson, C. V., Serrano, L., Hartl, F. U., Baumeister, W. P., Werenskiold, A. K., Andersen, J., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.017731 · Cited by 76
Zhou, Q., Yu, H., Chen, Y., Ren, J., Lü, Y., & Sun, Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320655121 · Cited by 76
Largazole and Its Derivatives Selectively Inhibit Ubiquitin Activating Enzyme (E1)
Ungermannova, D., Parker, S. J., Nasveschuk, C. G., Wang, W., Quade, B., Zhang, G., Kuchta, R. D., Phillips, A. J., & Liu, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029208 · Cited by 67
Liao, H., Liu, X. J., Blank, J. L., Bouck, D. C., Bernard, H., Garcia, K., & Lightcap, E. S. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009183 · Cited by 69
Jin, Y., Zhang, P., Wang, Y., Jin, B., Zhou, J., Zhang, J., & Pan, J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1703 · Cited by 68
Self-citationAgeta, H., & Tsuchida, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03246-7 · Cited by 68
Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader
Wei, J., Hu, J., Wang, L., Xie, L., Jin, M. S., Chen, X., Liu, J., & Jin, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01528 · Cited by 66
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
Veggiani, G., Gerpe, M. C. R., Sidhu, S. S., & Zhang, W. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.003 · Cited by 69
Kuo, K.-L., Ho, I.-L., Shi, C., Wu, J., Lin, W., Tsai, Y., Chang, H., Chou, C.-T., Hsu, C.-H., Hsieh, J., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.015 · Cited by 66
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G
Stanley, D. J., Bartholomeeusen, K., Crosby, D. C., Kim, D. Y., Kwon, E., Yen, L., Cartozo, N. C., Li, M., Jäger, S., Mason-Herr, J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003085 · Cited by 63
The NEDD8 modification pathway in plants
Mergner, J., & Schwechheimer, C. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00103 · Cited by 76
Gschweitl, M., Ulbricht, A., Barnes, C. A., Enchev, R. I., Stoffel-Studer, I., Meyer‐Schaller, N., Huotari, J., Yamauchi, Y., Greber, U. F., Helenius, A., et al. (2016) · eLife · doi:10.7554/elife.13841 · Cited by 67
Hammill, J. T., Bhasin, D., Scott, D. C., Min, J., Chen, Y., Lü, Y., Yang, L., Kim, H. S., Connelly, M., Hammill, C. V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01282 · Cited by 66
Ly, T., Whigham, A., Clarke, R. G., Murillo, A. B., Estes, B., Madhessian, D., Lundberg, E. K., Wadsworth, P., & Lamond, A. I. (2017) · eLife · doi:10.7554/elife.27574 · Cited by 67
Cullin Ring Ubiquitin Ligases (CRLs) in Cancer: Responses to Ionizing Radiation (IR) Treatment
Fouad, S., Wells, O. S., Hill, M. A., & D’Angiolella, V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01144 · Cited by 74
Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond
Zhao, B., Tsai, Y. C., Jin, B., Wang, B., Wang, Y., Zhou, H., Carpenter, T., Weissman, A. M., & Yin, J. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015651 · Cited by 70
Discovery of a Potent and Selective Degrader for USP7
Pei, Y., Fu, J., Shi, Y., Zhang, M., Luo, G., Luo, X., Song, N., Mi, T., Yang, Y., Li, J. X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204395 · Cited by 72
Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation
He, X., Riceberg, J., Pulukuri, S. M. K., Grossman, S., Shinde, V., Shah, P., Brownell, J. E., Dick, L. R., Newcomb, J. R., & Bence, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123882 · Cited by 65
Self-citationMackintosh, C., García-Domínguez, D. J., Ordóñez, J. L., Ginel-Picardo, A., Smith, P. G., Sacristán, M. P., & de Álava, E. (2012) · Oncogene · doi:10.1038/onc.2012.153 · Cited by 66
Self-citation14-3-3 Proteins Play a Role in the Cell Cycle by Shielding Cdt2 from Ubiquitin-Mediated Degradation
Dar, A., Wu, D., Lee, N. C. J., Shibata, E., & Dutta, A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00838-14 · Cited by 65
The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway
Cesare, V. D., Johnson, C., Barlow, V. L., Hastie, C. J., Knebel, A., & Trost, M. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.06.004 · Cited by 65
Zhou, S., Zhao, X., Yang, Z., Yang, R., Chen, C., Zhao, K., Wang, W., Ma, Y., Zhang, Q., & Wang, X. (2019) · International Journal of Cancer · doi:10.1002/ijc.32379 · Cited by 68
Lobato-Gil, S., Heidelberger, J. B., Maghames, C. M., Bailly, A., Brunello, L., Rodríguez, M. S., Beli, P., & Xirodimas, D. P. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108635 · Cited by 67
Current treatment of AL amyloidosis
Palladini, G. O., & Merlini, G. (2009) · Haematologica · doi:10.3324/haematol.2009.008912 · Cited by 65
Xu, J., Yu, X., Martin, T. C., Bansal, A., Cheung, K., Lubin, A., Stratikopoulos, E., Cahuzac, K. M., Wang, L., Xie, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0815 · Cited by 65
The COP9 signalosome: A versatile regulatory hub of Cullin-RING ligases
Schulze, E., & Naumann, M. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.08.003 · Cited by 64
Major roles of the circadian clock in cancer
Huang, C. L., Zhang, C., Cao, Y., Li, J., & Bi, F. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0474 · Cited by 71
Chou, T.-F., & Deshaies, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215319 · Cited by 64
Merlin, a multi‐suppressor from cell membrane to the nucleus
Zhou, L., & Hanemann, C. O. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.016 · Cited by 73
Re-replication induced by geminin depletion occurs from G2 and is enhanced by checkpoint activation
Klotz‐Noack, K., McIntosh, D., Schurch, N., Pratt, N., & Blow, J. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.100883 · Cited by 64
Tanaka, T., Nakatani, T., & Kamitani, T. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.003 · Cited by 69
SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development
Raducu, M., Fung, E., Serres, S., Infante, P., Barberis, A., Fischer, R., Bristow, C. A., Thézénas, M., Finta, C., Christianson, J. C., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593374 · Cited by 73
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target
Xie, P., Yang, J.-P., Cao, Y., Peng, L.-X., Zheng, L.-S., Sun, R., Meng, D.-F., Wang, M.-Y., Mei, Y., Qiang, Y.-Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.195 · Cited by 61
Strategies to Target ISG15 and USP18 Toward Therapeutic Applications
Fernandez, D. J., Hess, S., & Knobeloch, K. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00923 · Cited by 67
Assembly and Regulation of CRL Ubiquitin Ligases
Wang, K., Deshaies, R. J., & Liu, X. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_3 · Cited by 65
Calandrini, C., van Hooff, S. R., Paassen, I., Ayyildiz, D., Derakhshan, S., Dolman, M. E. M., Langenberg, K. P. S., van de Ven, M., de Heus, C., Liv, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109568 · Cited by 65
Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
Hwang, J., Lee, A., & Kho, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095053 · Cited by 64
Zhong, H., Ma, V. P., Cheng, Z., Chan, D. S., He, H., Leung, K., Ma, D., & Leung, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.004 · Cited by 63
Su, H., Li, J., Osińska, H. E., Li, F., Robbins, J. M., Liu, J., Wei, N., & Wang, X. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000338 · Cited by 64
Blees, J. S., Bokesch, H. R., Rübsamen, D., Schulz, K., Milke, L., Bajer, M. M., Gustafson, K. R., Henrich, C. J., McMahon, J. B., Colburn, N. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046567 · Cited by 62
SPOP mutation induces DNA methylation via stabilizing GLP/G9a
Zhang, J., Gao, K., Xie, H., Wang, D., Zhang, P., Wei, T., Yan, Y., Pan, Y., Ye, W., Chen, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25951-3 · Cited by 62
Self-citationHeterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma
Vilà, P. C., Ravichandra, A., Lizaso, A. A., Perugorria, M. J., & Affò, S. (2023) · Hepatology · doi:10.1097/hep.0000000000000206 · Cited by 72
Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis
Su, Y., Luo, Y., Zhang, P., Lin, H., Pu, W., Zhang, H., Wang, H., Hao, Y., Xiao, Y., Zhang, X., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.010 · Cited by 66
Lu, G. X., Yi, J., Gubaš, A., Wang, Y., Wu, Y., Ren, Y., Wu, M., Shi, Y. P., Ouyang, C., Tan, H. W. S., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596484 · Cited by 64
Chen, Y.-A., Peng, Y.-J., Hu, M.-C., Huang, J.-J., Chien, Y.-C., Wu, J.-T., Chen, T.-Y., & Tang, C.-Y. (2015) · Scientific Reports · doi:10.1038/srep10667 · Cited by 61
Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
Xue, G., Xie, J., Hinterndorfer, M., Cigler, M., Dötsch, L., Imrichová, H., Lampe, P., Cheng, X., Adariani, S. R., Winter, G. E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43657-6 · Cited by 64
Lee, J. E., Sweredoski, M. J., Graham, R. L. J., Kolawa, N. J., Smith, G. T., Hess, S. Y., & Deshaies, R. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.006460 · Cited by 61
Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer
Xie, C., Wei, W., & Sun, Y. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.02.001 · Cited by 61
Robertson, R., Germanos, M. S., Manfredi, M. G., Smith, P. G., & Silva, M. D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.091710 · Cited by 61
Self-citationInterrogating the Roles of Post-Translational Modifications of Non-Histone Proteins
Buuh, Z. Y., Lyu, Z., & Wang, R. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01817 · Cited by 65
Active Protein Neddylation or Ubiquitylation Is Dispensable for Stress Granule Dynamics
Markmiller, S., Fulzele, A., Higgins, R., Leonard, M., Yeo, G. W.-M., & Bennett, E. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.015 · Cited by 62
Cyclin F‐dependent degradation of E2F7 is critical for DNA repair and G2‐phase progression
Yuan, R., Liu, Q., Segeren, H. A., Yuniati, L., Guardavaccaro, D., Lebbink, R. J., Westendorp, B., & de Bruin, A. (2019) · The EMBO Journal · doi:10.15252/embj.2018101430 · Cited by 63
UBC12 ‐mediated SREBP ‐1 neddylation worsens metastatic tumor prognosis
Heo, M. J., Kang, S. H., Kim, Y. S., Lee, J. M., Yu, J., Kim, H., Lim, H., Kim, K. M., Jung, J., Jeong, L. S., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33113 · Cited by 64
Self-citationThe P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability
Bett, J. S., Ibrahim, A. F. M., Garg, A. K., Kelly, V. C., Pedrioli, P. G. A., Rocha, S., & Hay, R. T. (2013) · Biochemical Journal · doi:10.1042/bj20130026 · Cited by 64
Identifying the Ubiquitin Ligase Complex That Regulates the NF1 Tumor Suppressor and Ras
Hollstein, P. E., & Cichowski, K. M. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0146 · Cited by 67
Development of Activity-Based Probes for Ubiquitin and Ubiquitin-like Protein Signaling Pathways
An, H., & Statsyuk, A. V. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4099643 · Cited by 60
Guiding Mitotic Progression by Crosstalk between Post-translational Modifications
Cuijpers, S. A. G., & Vertegaal, A. C. O. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.02.004 · Cited by 61
Ju, U.-I., Jeong, D., Seo, J., Park, J. B., Park, J., Suh, K., Kim, J. B., & Chun, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2472-6 · Cited by 62
Jia, X., Li, C., Li, L., Liu, X., Zhou, L., Zhang, W., Ni, S., Lu, Y., Chen, L., Jeong, L. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2434 · Cited by 65
Self-citationFhu, C. W., & Ali, A. (2021) · Cancers · doi:10.3390/cancers13071513 · Cited by 63
Gong, T., Jiang, Y., Shao, C., Peng, W., Liu, M., Li, D., Zhang, B.-Y., Du, P., Huang, Y., Li, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110460 · Cited by 62
Xu, T., Ma, Q., Li, Y., Yu, Q., Pan, P., Zheng, Y., Li, Z., Xiong, X., Hou, T., Yu, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01182-w · Cited by 63
Jia, L., Bickel, J. S., Wu, J., Morgan, M. A., Li, H., Yang, J., Yu, X., Chan, R. C., & Sun, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188425 · Cited by 61
Neddylation-Induced Conformational Control Regulates Cullin RING Ligase Activity In Vivo
Boh, B. K., Smith, P. G., & Hagen, T. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.023 · Cited by 59
Self-citationKovačević, I., Sakaue, T., Majolée, J., Pronk, M. C. A., Maekawa, M., Geerts, D., Fernandez‐Borja, M., Higashiyama, S., & Hordijk, P. L. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201606055 · Cited by 63
RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response
Li, C., Zhang, L., Qian, D., Cheng, M., Hu, H., Hong, Z., Cui, Y., Yu, H., Wang, Q., Zhu, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009401 · Cited by 63
Saurat, N. G., Minotti, A. P., Rahman, M. T., Sikder, T., Zhang, C., Cornacchia, D., Jungverdorben, J., Ciceri, G., Betel, D., & Studer, L. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.001 · Cited by 64
NEDDylation controls the target specificity of E2F1 and apoptosis induction
Aoki, I., Higuchi, M., & Gotoh, Y. (2012) · Oncogene · doi:10.1038/onc.2012.428 · Cited by 67
Rao, F., Xu, J., Khan, A. W., Gadalla, M. M., Cha, J. Y., Xu, R., Tyagi, R., Dang, Y., Chakraborty, A., & Snyder, S. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417900111 · Cited by 58
Jimeno, S., Fernández-Ávila, M. J., Cruz-García, A., Cepeda-García, C., Gómez-Cabello, D., & Huertas, P. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1384 · Cited by 62
Wang, Y., Luo, Z., Pan, Y., Wang, W., Zhou, X., Jeong, L. S., Chu, Y., Liu, J., & Jia, L. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1003003 · Cited by 62
Li, X., Yokoyama, N. N., Zhang, S., Ding, L., Liu, H., Lilly, M. B., Mercola, D., & Zi, X. (2015) · Oncotarget · doi:10.18632/oncotarget.6166 · Cited by 58
Pellegrino, N., Güven, A., Gray, K., Shah, P., Kasture, G., Nastke, M.-D., Thakurta, A., Gesta, S., Vishnudas, V. K., Narain, N. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073480 · Cited by 63
Babaei, H., Nejad, Z. G., Yaghmaei, S., & Farhadi, F. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142050 · Cited by 60
Short, N. J., Müftüoğlu, M., Ong, F., Nasr, L. F., Macaron, W., Bravo, G. M., Alvarado, Y., Basyal, M., Daver, N. G., Dinardo, C. D., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01476-8 · Cited by 61
Dengler, M. A., Weilbacher, A., Gutekunst, M., Staiger, A. M., Vöhringer, M. C., Horn, H., Ott, G., Aulitzky, W. E., & van der Kuip, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.552 · Cited by 59
Zhou, L., Chen, S., Zhang, Y., Kmieciak, M., Leng, Y., Li, L., Lin, H., Rizzo, K., Dumur, C. I., Ferreira‐Gonzalez, A., et al. (2016) · Blood · doi:10.1182/blood-2015-06-653717 · Cited by 58
Self-citationJang, S., Redon, C. E., & Aladjem, M. I. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00019 · Cited by 60
Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Seimiya, T., Suzuki, T., Tanaka, E., Ishibashi, R., Funato, K., et al. (2018) · Hepatology · doi:10.1002/hep.30491 · Cited by 57
Metadata
- Authors
- Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., Cullis, C. A., Doucette, A., Garnsey, J. J., Gaulin, J. L., Gershman, R. E., Lublinsky, A. R., McDonald, A., Mizutani, H., Narayanan, U., Olhava, E. J., Peluso, S., Rezaei, M., Sintchak, M. D., Talreja, T., Thomas, M. P., Traore, T., Vyskocil, S., Weatherhead, G. S., Yu, J., Zhang, J., Dick, L. R., Claiborne, C. F., Rolfe, M., Bolen, J. B., & Langston, S. P.
- Affiliations
- Takeda Oncology (United States) (US)
- Corresponding author
- Soucy, Teresa A.
- ORCID
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7239
- Pages
- 732-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076194625
- Cited by
- 1,990
- References
- 46
- Citations by year
- 2026: 110 · 2025: 120 · 2024: 156 · 2023: 126 · 2022: 137 · 2021: 155 · 2020: 170 · 2019: 149 · 2018: 112 · 2017: 105 · 2016: 108 · 2015: 98 · 2014: 99 · 2013: 100 · 2012: 100
- FWCI
- 32.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- NEDD8-activating enzyme, MLN4924, cullin-RING ubiquitin ligases, ubiquitin-proteasome system, proteasome inhibitors, cancer cell death, tumor xenografts, small molecule inhibitors, antitumour activity
- MeSH terms
- NEDD8 Protein, Animals, Antineoplastic Agents, Cells, Cultured, Cyclopentanes, Enzyme Inhibitors, Female, Humans, Neoplasms, Pyrimidines, Transplantation, Heterologous, Ubiquitins, Ubiquitin-Activating Enzymes, Cullin Proteins, Cell Line, Tumor, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.